A new mouse study in Cell Death Discovery reports ketamine may protect ovarian function and improve egg quality in a stress-induced depression model. Researchers led by Liu, Jiang, Wang and colleagues tied the reproductive benefits to ferroptosis-related mechanisms, linking a cell-death pathway to fertility outcomes in chronically stressed animals. The work adds a mechanistic layer to ketamine’s fast-acting antidepressant profile by proposing potential off-target or broader tissue effects—at least in preclinical settings. The study’s key finding is that ketamine modulates ferroptosis, correlating with preserved ovarian performance and improved oocyte characteristics. While clinical translation remains uncertain, the result reinforces a continued push to map how central nervous system drugs can impact peripheral organs through defined molecular pathways.